Edmund K Waller

USPTO Granted Patents = 14 (Patent Applications = 8)

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 40(Granted Patents)

Company Filing History:

Georgia Tech Research Corporation

patents

where one patent can have more than one assignee

Years Active: 1998-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12098180 - Compositions and uses of vasoactive intestinal peptide (VIP) antagonists (2024-09-24),

2. 11859208 - Methods of treating cancer using cell based therapies (2024-01-02),

3. 11850263 - Nanoparticles conjugated with vasoactive intestinal peptide antagonists (2023-12-26),

4. 11786580 - VIP and VIP agonists, nanoparticles, and uses in inflammatory T-cell mediated disease (2023-10-17),

5. 11471506 - VIP antagonists and uses in treating cancer (2022-10-18),

6. 11464855 - Antagonism of the VIP signaling pathway (2022-10-11),

7. 10154989 - Methods of managing graft versus host disease (GvHD) using indole carboxyaldehydes or derivatives thereof (2018-12-18),

8. 9669092 - Antagonism of the VIP signaling pathway (2017-06-06),

9. 9458217 - Methods of managing graft versus host disease (2016-10-04),

10. 8486408 - Methods for the treatment of graft-versus-host disease (2013-07-16),

11. 6517830 - Compositions and methods for the expression of factor VIII polypeptides and uses therefor (2003-02-11),

12. 6213127 - Methods for treating cancer using allogeneic lymphocytes without graft vs host disease activity (2001-04-10),

13. 6060643 - Mouse model with human immune system (2000-05-09),

14. 5800539 - Method of allogeneic hematopoietic stem cell transplantation without (1998-09-01),

Title: Inventor Edmund K Waller: Pioneering Advances in Cancer Treatment

Introduction

Edmund K Waller, based in Atlanta, GA, is a distinguished inventor known for his significant contributions to the fields of cancer therapy and immunology. With a remarkable portfolio of 14 patents, Waller's innovative work focuses on the development of peptides and methodologies aimed at advancing cancer treatment and viral infection management.

Latest Patents

Waller's recent patents include groundbreaking disclosures related to compositions and applications of vasoactive intestinal peptide (VIP) antagonists. These VIP antagonists are designed to manage the treatment or prevention of cancer and viral infections. His innovation encompasses chimeric variants of VIP antagonists, along with pharmaceutical compositions comprising these peptides. Notably, his work discusses methods for stimulating immune cells to target cancer by enriching immune cells in vitro with the disclosed peptides, which are then administered effectively to patients in need of cancer treatment. Additionally, Waller's patents outline methods of treating cancer using cell-based therapies by reversing senescence in T cells through interrupting VIP signaling and inhibiting phosphatidylinositol-3-kinase (PI3K) signaling. This involves the use of agents that block VIP interaction with its receptors and PI3K inhibitors, ultimately aiming to enhance T cell efficacy in combating cancer and chronic viral infections.

Career Highlights

Throughout his career, Edmund K Waller has established a strong foothold in the realms of research and academia. He has been affiliated with prestigious institutions such as Emory University and Georgia Tech Research Corporation, where he has leveraged his expertise to pioneer research initiatives centered on immune response and cancer treatment modalities.

Collaborations

Waller has collaborated closely with esteemed colleagues, including Jian-Ming Li and Mohammad S Hossain, to advance his research endeavors. These collaborations have fostered a dynamic exchange of ideas and innovations, further enriching the scientific community's understanding of immunological therapies.

Conclusion

As an inventor, Edmund K Waller exemplifies dedication to transformative research in cancer treatment and immunotherapy. His innovative patents not only reflect a commitment to scientific advancement but also promise to play a crucial role in the future of medical therapies aimed at combating cancer and viral infections. Through his work, Waller continues to inspire future generations of inventors and researchers in the field of life sciences.

This text is generated by artificial intelligence and may not be accurate.